Overbought Stocks — Performance View · Nasdaq 100 Companies
5 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Performance columns. Filtered to Nasdaq 100 Companies. Data as of close · Checked
| REGN | Regeneron Pharmaceuticals | +19.35% | +34.10% | +25.65% | +38.65% | +49.47% | +26.16% | 4.2% | 2.8% | 1.60 | 37K | 973.80 | +1.30% | 59K |
| GEHC | GE HealthCare | +13.50% | +22.65% | +14.81% | +32.13% | +7.61% | -1.67% | 3.1% | 2.6% | 1.46 | 178K | 80.64 | +1.34% | 260K |
| IDXX | Idexx Laboratories | +19.80% | +27.60% | +14.98% | +19.54% | +6.49% | -0.65% | 4.6% | 2.7% | 1.60 | 39K | 672.26 | +0.10% | 62K |
| MAR | Marriott International | +6.68% | +16.95% | +15.22% | +17.40% | +59.72% | +34.13% | 2.6% | 2.2% | 0.94 | 76K | 416.32 | -0.03% | 72K |
| ROP | Roper Technologies | +7.56% | +28.68% | +18.52% | +31.08% | +4.75% | +4.99% | 2.9% | 2.5% | 1.63 | 43K | 467.42 | -2.53% | 70K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.